sameAs
Discovery pipeline for epigenetically deregulated miRNAs in cancer: integration of primary miRNA transcriptionCollagen and calcium-binding EGF domains 1 is frequently inactivated in ovarian cancer by aberrant promoter hypermethylation and modulates cell migration and survivalPermissive transcriptional activity at the centromere through pockets of DNA hypomethylation.ELF5 Drives Lung Metastasis in Luminal Breast Cancer through Recruitment of Gr1+ CD11b+ Myeloid-Derived Suppressor CellsMutation and methylation analysis of TP53 in adrenal carcinogenesis.BayMeth: improved DNA methylation quantification for affinity capture sequencing data using a flexible Bayesian approachZNF300P1 encodes a lincRNA that regulates cell polarity and is epigenetically silenced in type II epithelial ovarian cancerNGSANE: a lightweight production informatics framework for high-throughput data analysis.Impact of the genome on the epigenome is manifested in DNA methylation patterns of imprinted regions in monozygotic and dizygotic twinsGenomic profiling of CpG methylation and allelic specificity using quantitative high-throughput mass spectrometry: critical evaluation and improvements.Repitools: an R package for the analysis of enrichment-based epigenomic data.Comprehensive evaluation of genome-wide 5-hydroxymethylcytosine profiling approaches in human DNA.Circulating microRNAs are associated with docetaxel chemotherapy outcome in castration-resistant prostate cancer.Evaluation of affinity-based genome-wide DNA methylation data: effects of CpG density, amplification bias, and copy number variationEpigenome remodelling in breast cancer: insights from an early in vitro model of carcinogenesisEpigenetic deregulation across chromosome 2q14.2 differentiates normal from prostate cancer and provides a regional panel of novel DNA methylation cancer biomarkers.Methylation-capture and Next-Generation Sequencing of free circulating DNA from human plasmaMicroRNA alterations and associated aberrant DNA methylation patterns across multiple sample types in oral squamous cell carcinoma.Coordinated epigenetic repression of the miR-200 family and miR-205 in invasive bladder cancer.Reconfiguration of nucleosome-depleted regions at distal regulatory elements accompanies DNA methylation of enhancers and insulators in cancer.Copy-number-aware differential analysis of quantitative DNA sequencing dataDNA methylation of oestrogen-regulated enhancers defines endocrine sensitivity in breast cancer.ELF5 suppresses estrogen sensitivity and underpins the acquisition of antiestrogen resistance in luminal breast cancer.Consolidation of the cancer genome into domains of repressive chromatin by long-range epigenetic silencing (LRES) reduces transcriptional plasticityDNA methylation and gene silencing in cancer: which is the guilty party?DNA methylation changes in leukaemia.Protocol matters: which methylome are you actually studying?Profiling the tyrosine phosphoproteome of different mouse mammary tumour models reveals distinct, model-specific signalling networks and conserved oncogenic pathways.Multiplex bisulfite PCR resequencing of clinical FFPE DNA.Coordinated epigenetic remodelling of transcriptional networks occurs during early breast carcinogenesis.De novo identification of differentially methylated regions in the human genome.Methylated Glutathione S-transferase 1 (mGSTP1) is a potential plasma free DNA epigenetic marker of prognosis and response to chemotherapy in castrate-resistant prostate cancer.Acetylation of H2A.Z is a key epigenetic modification associated with gene deregulation and epigenetic remodeling in cancer.COBRA-Seq: Sensitive and Quantitative Methylome ProfilingGenome-wide nucleosome occupancy and DNA methylation profiling of four human cell lines.Bisulfite sequencing of chromatin immunoprecipitated DNA (BisChIP-seq) directly informs methylation status of histone-modified DNAMapping the regulatory sequences controlling 93 breast cancer-associated miRNA genes leads to the identification of two functional promoters of the Hsa-mir-200b cluster, methylation of which is associated with metastasis or hormone receptor status iAction at a distance: epigenetic silencing of large chromosomal regions in carcinogenesis.DNA methylation changes in ovarian cancer: implications for early diagnosis, prognosis and treatment.Epigenetic architecture and miRNA: reciprocal regulators.
P50
Q21267171-4233D8F6-13EC-4C54-8EE3-F47C78C0FDC6Q24655625-13D0017A-AD46-4C77-A346-5067DE90BF67Q25257502-85B34F4C-48AE-4CA8-8AD6-34D65D92AC3EQ27345430-AAB041BB-6C55-4A30-9504-BA16B660A2EAQ27824836-6915DEE5-C827-4AD7-97F4-62E06E1B6343Q28658401-92B23000-2C1E-4703-B568-316A9E3C9C80Q30565514-7D09394B-6A16-4B46-AC3B-8197047C5F10Q30743446-3B40453D-5C3E-452C-A65A-227345A66642Q31032416-336A0753-8966-45AD-AD67-74B28E34079FQ33298863-A39058F1-7A75-46CE-8659-D502E660163AQ33574328-8728E0F8-34E6-4333-A863-3AAEA2CD49EDQ33581992-F3716F06-CB8F-42EA-9C05-A6F6706B470AQ33613644-E8EA56AF-7FD2-488E-9A72-C8A4653DDEADQ33736481-AC8CBE7F-4CC5-47A6-9A40-73703CA19B9FQ33739319-2828D8E0-360A-40E8-80E9-11ECBAF53822Q33753677-E8C0A24D-783B-464A-9559-7454B6AF6D0AQ33832718-310CFEB9-8950-4FE5-B7BE-89F1443EA2AAQ34087915-4C8978A1-9970-4BE3-BACE-15034280F87AQ34115748-ED4E6A11-0F3C-4E39-A09F-0413586DAE0CQ34153828-BC8ACC73-20CF-41C2-88D0-1ED7F0CD61BFQ34373648-9C1B20DD-8A53-458F-808A-23A02DA64030Q34484781-168D9E97-9CBD-4044-B226-36739E504714Q34539617-4C65537F-91B0-4BB8-BEF3-D9A4D59B2D88Q34680105-E8CA51AB-9258-4C87-B540-99B4DDB8F090Q34770507-4D92D7BD-DD39-44B1-9D0B-98262461321DQ34792998-9EA7DAB3-E800-4B59-B909-3EC7AC615F81Q34955033-7A8FD1FF-8716-43A3-AB2D-668A9ADFFE33Q35000261-3D64185A-2B52-48E6-AA61-2A7EC865DED9Q35317700-06E885E8-1930-4A4C-BD04-0C9DEBCF0324Q35584026-020E39F2-9F53-4FDB-8505-36641A5197CEQ35599253-C24D2331-32ED-4E09-8040-CDA16814E387Q35678056-C5A220FF-4148-4E81-B385-3D885B54DE7FQ35694399-F652278B-B6FB-4F2F-BE58-28C663B9C088Q35825767-A8DEB741-0816-4710-8E9D-927FB8119E8AQ35951437-D5975EC3-3606-464F-9D88-A509D551838AQ36021714-147F0D63-1538-4270-8EA4-E6D7C2AAD52FQ36250545-A510A746-8431-4A4E-83D7-35BDB9DDE7F6Q36871625-97EB3FFE-8BE6-4CDE-9291-54D1F34BABFEQ37072060-255FC291-A23A-43BC-8574-0C28C97A6CF4Q37961805-35B13F42-9DD7-4B06-9B4A-7778FC3C6F82
P50
description
Australian biomedical researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Susan Clark
@ast
Susan Clark
@en
Susan Clark
@es
Susan Clark
@nl
Susan Clark
@sl
Susan Clark
@sq
Susan J. Clark
@de
Susan J. Clark
@fr
Susan J. Clark
@pt
Сьюзан Кларк
@ru
type
label
Susan Clark
@ast
Susan Clark
@en
Susan Clark
@es
Susan Clark
@nl
Susan Clark
@sl
Susan Clark
@sq
Susan J. Clark
@de
Susan J. Clark
@fr
Susan J. Clark
@pt
Сьюзан Кларк
@ru
altLabel
Susan J. Clark
@en
Susan J. Clark
@es
prefLabel
Susan Clark
@ast
Susan Clark
@en
Susan Clark
@es
Susan Clark
@nl
Susan Clark
@sl
Susan Clark
@sq
Susan J. Clark
@de
Susan J. Clark
@fr
Susan J. Clark
@pt
Сьюзан Кларк
@ru
P1053
B-2272-2008
P21
P31
P3829
P496
0000-0001-5925-5030